Which Medications Can Cause Dry Eye?

Various prescription and over-the-counter medications can increase the risk of developing dry eye syndrome, either by directly affecting the eyes or by causing other physical changes that indirectly impact the eyes.
If you’re experiencing dry eye, learning that a medication is the culprit can be a first step toward getting relief from stinging, redness, pain, light sensitivity, and other symptoms.
Antihistamines for Allergy Relief
Antihistamines cause dry eye by changing the composition and production of tears in two ways:
- By blocking receptors that regulate fluid secretion in the eye
- By blocking nerve signals needed to produce the right amounts of water and oil, resulting in fewer tears and a poor quality tear film
- Diphenhydramine (Benadryl)
- Loratadine (Claritin)
- Cetirizine (Zyrtec)
- Fexofenadine (Allegra)
Eye Drops
Decongestants
Antidepressants
Different types of antidepressants can cause dry eye in different ways.
SSRIs
- Citalopram (Celexa)
- Escitalopram (Lexapro)
- Fluoxetine (Prozac)
- Fluvoxamine (Luvox)
- Paroxetine (Paxil)
- Sertraline (Zoloft)
SNRIs
- Venlafaxine (Effexor)
- Desvenlafaxine (Pristiq)
- Duloxetine (Cymbalta)
Tricyclic Antidepressants
Anxiety Medications
Heart and Blood Pressure Medications
A variety of medications used to treat cardiovascular issues can lead to dry eye.
Beta-Blockers for Hypertension
- Carvedilol (Coreg)
- Labetalol (Trandate)
- Nebivolol (Bystolic)
Diuretics
Statins
- Atorvastatin (Lipitor)
- Rosuvastatin (Crestor)
- Simvastatin (Zocor)
Acne Medications
Isotretinoin (Accutane) manages acne by reducing oil production in the body. But it also reduces the oil needed for healthy tears, potentially leading to dry eye.
Isotretinoin can also damage the tissues of the meibomian gland, reducing the quality and effectiveness of tears, says Anat Galor, MD, spokesperson for the American Academy of Ophthalmology and cornea specialist at the University of Miami Health System.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
With long-term use, however, NSAIDs can reduce corneal sensitivity and may even damage the cornea. These changes can lower tear production, leading to dry eye.
- Ibuprofen (Advil)
- Diclofenac (Voltarol)
- Nepafenac (Nevanac)
Parkinson’s Disease Medications
Gastrointestinal Medications
PPI inhibitors and H2 blockers can ease digestive discomfort, but they may also lead to dry eye.
PPI Inhibitors
- Esomeprazole (Nexium)
- Lansoprazole (Prevacid)
- Omeprazole (Prilosec)
- Dexlansoprazole (Dexilant)
- Pantoprazole (Protonix)
- Rabeprazole (AcipHex)
H2 Blockers
Examples include:
- Cimetidine (Tagamet)
- Famotidine (Pepcid)
- Nizatidine (Axid)
Chemotherapy Medications
Consider the following:
- Taxanes This class of chemotherapy drugs, including paclitaxel (Taxol) and docetaxel (Taxotere), disrupts cell division, which may cause issues with the meibomian gland and obstruct the channels through which tears flow.
- S-1 chemo This chemo medication sometimes leads to severe meibomian gland issues, possibly due to toxins from the drug entering tears.
- Aromatase inhibitors Medications like letrozole (Femara) can lower the risk of breast cancer returning after treatment, but may increase the risk of dry eye, possibly due to a lower meibum production. However, more research is needed to confirm this connection.
Hormonal Birth Control and Other Hormone Treatments
Scientists have linked changes in various sex steroid hormones to dry eye.
Hormonal Birth Control
Anti-Androgen Therapy
Antipsychotic Medications
Diagnosing Drug-Induced Dry Eye
If you think you have dry eye, it’s best to see an ophthalmologist or eye doctor. Addressing dry eye early may help prevent future eye problems.
The doctor will likely ask about your:
- Symptoms
- Medical history
- Medication use
- Lifestyle habits, such as smoking
They may then carry out a dilated eye exam. The doctor will put drops in your eye to widen the pupil before examining it.
They will look for signs such as inflammation or damage to the eye’s surface.
- Tear volume In a Schirmer test, the doctor places blotting paper under your lower eyelid to see how much fluid collects in 5 minutes; in a phenol and red thread test, the doctor places a dye-filled thread over the lower eyelid for 15 seconds to see if the color alters due to a pH change.
- Tear quality Special dyes can reveal patterns on the eye’s surface linked to dry eye, along with tests to see how quickly tears evaporate.
- Tear osmolarity This test measures the composition of water to particles in tears; less water suggests dry eye.
- Biomarker tests The doctor takes tear samples to test in a laboratory for biomarkers of other diseases.
The doctor will then assess all of these factors to identify the most likely cause.
How to Manage Drug-Induced Dry Eye Disease
If a physician suspects your dry eye is due to a drug you’re taking, they may suggest you ask your prescribing doctor to assess your medication and possibly substitute a different drug.
However, the picture can be complex, Dr. Galor says, and simply identifying a single drug as the problem and eliminating it may not be the solution.
Solutions for treating dry eye caused by a medication might involve:
- Lowering the dose of the drug
- Changing to another drug
- Using artificial tears, available over the counter
- Applying ointments and gels to improve comfort
- Using prescription drugs “off label” to help increase tear production, such as cyclosporine (Restasis) or lifitegrast (Xiidra)
- Applying tear duct plugs to stop tears from draining away too fast
Steps for Managing Dry Eye at Home
- Using a humidifier
- Avoiding smoky atmospheres
- Avoiding or quitting smoking
- Keeping air from blowing into your eyes, as with a hair dryer
- Positioning your computer screen below eye level so you don’t open your eyes so wide
- Closing your eyes for a few minutes when in a dry environment
- Taking screen breaks
- Wearing goggles or wraparound sunglasses
- Getting enough vitamin A and omega-3 oil in your diet
The Takeaway
- A number of medications can cause or worsen dry eye, ranging from antihistamines to hormone therapies.
- Different drugs that cause dry eye have different biological pathways for creating the condition, and it’s not always clear why dry eye happens.
- Dry eye caused by medications usually stops when you stop taking the drug, but long-term use may cause permanent damage to eye tissue.
Resources We Trust
- Cleveland Clinic: Dry Eye
- Mayo Clinic: Dry Eyes
- American Academy of Ophthalmology: What Is Dry Eye? Symptoms, Causes and Treatment
- Penn Medicine: Dry Eye
- National Eye Institute: Dry Eye
- Dry Eye. National Eye Institute. February 2025.
- Guo M et al. Association Between Systemic Medication Use and Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study. The Ocular Surface. April 2024.
- Foutch BK et al. Effects of Oral Antihistamines on Tear Volume, Tear Stability, and Intraocular Pressure. Vision. June 2020.
- Katipoğlu Z et al. The Relationship Between Dry Eye Disease and Anticholinergic Burden. Eye. February 2023.
- Dry Eyes. Mayo Clinic. September 2022.
- Datta S et al. The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells. Investigative Ophthalmology & Visual Science. April 2017.
- Raval PM et al. Study of Dry Eye Syndrome: Focus on Causative Factors, Treatment Modalities, Quality of Life, and Preservatives Used in Eye Drops. Indian Journal of Ophthalmology. April 2023.
- Wong JC et al. Managing Dry Eye Disease with Novel Medications: Mechanism, Study Validity, Safety, Efficacy, and Practical Application. Pharmacy. January 2024.
- Gilberson Kuiken C et al. How Systemic Drugs Trigger Dry Eye Disease. Review of Optometry. November 2022.
- Unsal AIA et al. Ophthalmic Adverse Effects of Nasal Decongestants on an Experimental Rat. Arquivos Brasileiros de Oftalmologia. February 2018.
- Zhao H et al. Administration of Serotonin and Norepinephrine Reuptake Inhibitors Tends to Have Less Ocular Surface Damage in a Chronic Stress-Induced Rat Model of Depression Than Selective Serotonin Reuptake Inhibitors. Experimental Eye Research. June 2023.
- Ismayilov AS et al. Effects of Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, and Selective Serotonin-Norepinephrine Reuptake Inhibitors on the Ocular Surface. Arquivos Brasileiros de Oftalmologia. October 2023.
- Constable PA et al. A Review of Ocular Complications Associated with Medications Used for Anxiety, Depression, and Stress. Clinical Optometry. February 2022.
- Amitryptiline Tablets. Cleveland Clinic.
- Anticholergic Drugs. Cleveland Clinic. December 2024.
- Beta Blockers. Cleveland Clinic. January 2022.
- Rolando M et al. The Correct Diagnosis and Therapeutic Management of Tear Dysfunction: Recommendations of the P.I.C.A.S.S.O. Board. International Ophthalmology. April 2017.
- Kam KW et al. A Review on Drug-Induced Eye Disease. Indian Journal of Ophthalmology. April 2023.
- Zakrzewska A et al. The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris. Ophthalmology and Therapy. June 2023.
- Nguyen A et al. Dry Eye Disease: A Review of Anti-Inflammatory Therapies. Taiwan Journal of Ophthalmology. February 2023.
- Ungureanu L et al. Dry eye in Parkinson's disease: a narrative review. Frontiers in Neurology. August 2023.
- Wolpert LE et al. Medication Use and Dry Eye Symptoms: A Large, Hypothesis-free, Population-Based Study in the Netherlands. The Ocular Surface. October 2021.
- Proton Pump Inhibitors. Cleveland Clinic. September 2023.
- H2 Blockers. Cleveland Clinic. March 2024.
- He B et al. Effects of Hormonal Contraceptives on Dry Eye Disease: A Population-Based Study. Eye. April 2021.
- Mu C et al. Characteristics of Eye Disorders Induced by Atypical Antipsychotics: A Real-World Study from 2016 to 2022 Based on Food and Drug Administration Adverse Event Reporting System. Frontiers in Psychiatry. August 2024.
- Chokhawala K et al. Antipsychotic Medications. StatPearls. February 2023.
- Antipsychotic Medications. CAMH.
- Dixitha V et al. Quantitative Analysis of Tear Film in Patients on Atypical Antipsychotics. Ocular Immunology and Inflammation. July 2024.
- Dry Eyes: Diagnosis. Mayo Clinic. September 2022.

Michael W. Stewart, MD
Medical Reviewer
Michael W. Stewart, MD, is professor and chairman of ophthalmology at Mayo Clinic in Jacksonville, Florida, and the Knights Templar Eye Foundation Professor of Ophthalmology Research. He graduated with honors in chemistry from Harvard College in Cambridge, Massachusetts, and from the McGill University Faculty of Medicine in Montreal. He completed an internship in internal medicine at Jackson Memorial Hospital in Miami and an ophthalmology residency at Emory University in Atlanta. Dr. Stewart completed vitreoretinal fellowships at Touro Infirmary in New Orleans and at the University of California Davis.
His research interests include diabetic retinopathy, macular degeneration, retinal vein occlusions, and infectious retinitis. He has a particular interest in retinal pharmacology, pharmacokinetics, and the mathematical modeling of ocular diseases and treatments.

Yvette Brazier
Author
Yvette Brazier's career has focused on language, communication, and content production, particularly in health education and information. From 2005 to 2015, she supported learning in the health science department of a higher education establishment, teaching the language of health, research, and other language application skills to paramedic, pharmacy, and medical imaging students.
From 2015 to 2023, Yvette worked as a health information editor at Medical News Today and Healthline. Yvette is now a freelance writer and editor, preparing content for Everyday Health, Medical News Today, and other health information providers.